Tumor markers such as carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) are widely used for CRC diagnosis and monitoring and have established roles in detecting early recurrence [11,12]. Here, CEACAM5 is linked to colorectal carcinoma.